“GreenON” is Asia’s first digital service that lists green credentials of agri-producers under developmentNovember 9, 2021
Musim Mas, MUFG Bank, Danamon, and iAPPS Collaborate To Promote Financial Inclusion Among Independent SmallholdersJune 29, 2021
HeartVoice (Joint Venture of iAPPS and OMRON Healthcare) joins the fight against COVID-19 and extends its Telehealth platform to all healthcare providers in Singapore free-of-charge.
A Response to the Need for Remote Health Management
To support safe distancing amongst the public and contribute to the evolving COVID-19 situation, HeartVoice will extend its Telehealth platform to all healthcare providers.
Leveraging on the expertise and industry experiences of both iAPPS and OMRON Healthcare, HeartVoice brings together a suite of healthcare technological solutions in the form of remote patient monitoring, kiosk* and teleconsultation – all integrated into a secure and user-friendly platform.
Remote Patient Monitoring
In the comfort of their homes, patients can choose to manually enter their vital signs using the free HeartVoice App or track them using Bluetooth-enabled devices with instantaneous transfer of that data to their Doctor’s Dashboard. Healthcare providers can also adopt the use of HeartVoice kiosk in their clinics to help patients seamlessly capture their vital signs and keep track of their records.
Healthcare providers can in turn obtain real-time and reliable vital signs recordings at a glance and customise an accurate personalised treatment plan for their patients. The Doctor Dashboard also allows for healthcare providers to set thresholds, sort and filter patients to perform necessary interventions.
Seamless Telemedicine Experience
Aside from Remote Patient Monitoring, HeartVoice provides a comprehensive Teleconsultation solution. Key features include an integrated appointment booking system, high quality video consultation experience, personalised medication delivery and a secure online payment gateway.
An early adopter of HeartVoice’s Telehealth platform, Adj Asst/Prof Lim Hong Shen, Medical Director of A Medical Clinic, Everton Park remarked “The COVID-19 pandemic has brought significant challenges to our healthcare systems and in particular its mode of delivery. Telemedicine has certainly taken on a new significance in today’s delivery of healthcare and it is important that we implement it safely and effectively.”
HeartVoice is a joint venture by iAPPS Pte Ltd and OMRON Healthcare Co. Ltd.
Having collaborated with ActiveSG for years, iAPPS has the technology expertise to offer booking and payment services to more than 1.8 million users in Singapore. OMRON Healthcare is a global corporation and leading manufacturer of medical devices, such as blood pressure monitors.
To support the larger healthcare community in the fight against COVID-19, HeartVoice will be waiving its platform fees until July 31, 2020, so that healthcare professionals can provide teleconsultation services to their patients without any upfront investment. Every provider will be guided throughout the setup process by HeartVoice’s support team to ensure a seamless onboarding.
In addition, for participating healthcare providers who successfully enrol with the HeartVoice Telehealth platform by 1st of June 2020, Heartvoice will provide its health kiosk till 31st of July 2020 at no cost.
*HeartVoice kiosk is a compact kiosk that consists of OMRON Bluetooth-enabled blood pressure and body composition monitors connected to an iPad with deployed HeartVoice application. At the kiosk, patients can monitor their health vitals, such as blood pressure and heart rate, synchronizing their health readings to their HeartVoice personalised app.
For Doctors -> Start using HeartVoice Telehealth platform to treat your patients now!
For Patients -> Check with your Doctor whether they use HeartVoice Platform, or visit HeartVoice website for more information
iAPPS Pte Ltd Joins IBM Blockchain World Wire
Expanded Services Now Offered Through New Cross-Border Payments Network Supporting Real Time Payments and Foreign Exchange on the Stellar Protocol
SINGAPORE, 18 MARCH 2019 – iAPPS PTE. LTD. today announced it will join IBM Blockchain World Wire, a real-time global payments network for regulated financial institutions, designed to optimize and accelerate foreign exchange and remittance services.
By connecting to the World Wire network, iAPPS now has access to a single unified network for foreign exchange and cross-border payments clearing and settlement built on blockchain technology and the Stellar public protocol. This will allow iAPPS to offer clients the ability to conduct transactions across additional currency corridors and provide access to new digital assets including stable coins and cryptocurrency using Stellar Lumens (XLM).
“We are very excited about the launch of IBM World Wire! With this new blockchain solution, we are now able to link up with reliable partners overseas to offer near real-time remittance service to our customers in Singapore!” said Ms Lilian Koh, CEO and founder of iAPPS Pte. Ltd..
World Wire enables regulated financial institutions to expand their business ecosystems more rapidly, while improving financial inclusion for people around the world through highly secure, point-to-point payment transactions.
“Blockchain provides a transparent, technology layer for payments,” said Jesse Lund, Global Vice President, IBM Blockchain. “Using distributed ledger technology, World Wire can be used to optimize financial flows worldwide by allowing institutions such as iAPPS to connect to the network APIs, see exchange rate quotes in real-time, and record transaction details onto an immutable blockchain for easy auditing and reconciliation. This reduces the need for intermediaries and long durations for clearing and settlements – which ultimately can get money into consumers’ hands faster and more efficiently.”
The World Wire network is poised to support more than 50 countries, with 20+ currencies and more than 30 banking end points and at least 1081 distinct currency trading pairs with more being actively added based upon client demand.
For more information about iAPPS PTE LTD:
For more information about IBM Blockchain World Wire: https://www.ibm.com/blockchain/solutions/world-wire
SINGAPORE, 28 February 2019 – OMRON HEALTHCARE Co., Ltd. and iAPPS Pte. Ltd. today announced the establishment of HeartVoice Pte. Ltd., a joint venture that provides health management services to businesses. Amid increasing attention placed on preventive healthcare, HeartVoice aims to help businesses manage and improve the health of their employees. Services provided by HeartVoice are designed to help employees reduce the risk of prevalent health conditions such as cardiovascular disease and diabetes.
Businesses and individuals bear 60 percent (*1) of all healthcare expenditure in Singapore. With healthcare cost growing at an annual rate of 7 percent (*2), the government has increasingly been emphasizing the importance of preventive healthcare. Companies today are also adopting a preventive healthcare approach as a more sustainable way to cater to their employees’ health requirements.
Entrusted by the Singapore government, iAPPS develops and operates the booking and payment system, called “ActiveSG,” for more than 20 sports centers islandwide. To-date, ActiveSG membership has exceeded 1.6 million and it has grown beyond facility and programme booking to become a channel to encourage positive behavioral changes, such as making exercise a daily habit through digital communication, competitions and innovative incentive programs.
OMRON HEALTHCARE is committed to solving the social issue of soaring medical expenditures caused by chronic lifestyle diseases. In Singapore, the company markets home-use healthcare devices such as blood pressure monitors and body composition monitors, while providing healthcare support through the “OMRON connect” mobile app for health data management.
The new company HeartVoice will leverage iAPPS’s account management and financial technologies, as well as its knowhow of designing and implementing successful incentive programs and systems. The company will also draw on OMRON HEALTHCARE’s extensive portfolio of personal use healthcare devices such as blood pressure and body composition monitors, to provide key health indicators. OMRON HEALTHCARE’s expertise in home blood pressure management will also be used to develop a health management service platform, “HeartVoice”. Aimed at helping Singapore-based businesses which care for the general well-being of their employees, “HeartVoice” is designed primarily to prevent the onset and progression of hypertension and other lifestyle diseases of their employees. On the longer run, HeartVoice will adapt and extend the business experience it will acquire in Singapore to other Asian countries.
“As a leading company in the field of cardiovascular business, OMRON HEALTHCARE has set forth a business concept of reducing cerebrovascular and cardiovascular diseases caused by high blood pressure, such as stroke and heart attack to zero (Zero Events). To this end, preventative care and active monitoring is fundamental.” said Isao Ogino, President and CEO of OMRON HEALTHCARE Co., Ltd. “This joint venture furthers our commitment to realize “Zero Events” and, improving lives and contributing to a better society”.
“We are very excited and look forward to this collaboration with OMRON HEALTHCARE to bring healthcare devices to where they are needed the most and to make preventive healthcare an integral part of everyday living through HeartVoice, our mobile app.” said Ms Lilian Koh, CEO and Founder of iAPPS Pte. Ltd..
Besides providing preventive healthcare monitoring services for businesses, HeartVoice is also working on developing a remote healthcare monitoring service for hypertensive patients. Once developed, HeartVoice will collaborate with clinics and medical institutions in Singapore and other countries in the region to provide hypertensive patients with blood pressure monitors and remote therapy tools.
(*1): BMI Research report
(*2): WHO Expenditure database
About OMRON HEALTHCARE Co., Ltd.
Committed to improving people’s lives, OMRON HEALTHCARE provides clinically proven, innovative medical equipment for health monitoring and therapy. Our product portfolio includes blood pressure monitors, nebulizer, electronic thermometers, blood glucose monitors and activity counters as well as body composition monitors and professional medical devices. For many decades, OMRON’s devices have helped people to prevent, treat and manage lifestyle diseases both at home and in clinical practice in more than 100 countries in the world. OMRON HEALTHCARE Group is headquartered in Muko City, Kyoto Prefecture, Japan. Its President is Isao Ogino.
About iAPPS Pte. Ltd.
iAPPS is a pioneer financial technology company specialised in mobile app development and marketing. Headquartered in Singapore, it was awarded the 2014 Red Herring Top 100 Global and 2014 Red Herring Top 100 Asia. “ActiveSG”, launched in 2014, has remained the company’s most prominent product, with more than 1.6 million users. The app empowers ‘ActiveSG’, a national sports initiative by the Singapore government.
iAPPS Pte Ltd. Selected as a 2014 Red Herring Top 100 Global
PASADENA, Calif.—November 20, 2014—Red Herring announced its Top 100 Global in recognition of the leading private companies from North America, Europe, and Asia today, celebrating these startups’ innovations and technologies across their respective industries.
Red Herring’s Top 100 Global list has become a mark of distinction for identifying promising new companies and entrepreneurs. Red Herring editors were among the first to recognize that companies such as Facebook, Twitter, Google, Yahoo, Skype, Salesforce.com, YouTube, and eBay would change the way we live and work.
“Choosing the companies with the strongest potential was by no means a small feat,” said Alex Vieux, publisher and CEO of Red Herring. “After rigorous contemplation and discussion, we narrowed our list down from hundreds of candidates from across the globe to the Top 100 Winners. We believe iAPPS Pte Ltd embodies the vision, drive and innovation that define a successful entrepreneurial venture. iAPPS Pte Ltd should be proud of its accomplishment.”
Red Herring’s editorial staff evaluated the companies on both quantitative and qualitative criteria, such as financial performance, technology innovation, management quality, strategy, and market penetration. This assessment of potential is complemented by a review of the track records and standing of startups relative to their peers, allowing Red Herring to see past the “buzz” and make the list a valuable instrument of discovery and advocacy for the most promising new business models from around the world.